We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

79 hedge funds and large institutions have $106M invested in Cytosorbents Corp in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

268% more call options, than puts

Call options by funds: $776K | Put options by funds: $211K

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

18% more capital invested

Capital invested by funds: $89.2M → $106M (+$16.5M)

18% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 22

5% more funds holding

Funds holding: 75 → 79 (+4)

0.06% less ownership

Funds ownership: 26.11% → 26.06% (-0.06%)

Holders
79
Holders Change
+4
Holders Change %
+5.33%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
26
Reduced
22
Closed
9
Calls
$776K
Puts
$211K
Net Calls
+$565K
Net Calls Change
-$307K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.2M
2
USAA
United Services Automobile Association
Texas
+$2.4M
3
Invesco
Invesco
Georgia
+$2.39M
4
GIM
Granahan Investment Management
Massachusetts
+$2.35M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
2
Two Sigma Investments
Two Sigma Investments
New York
-$2.23M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.25M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$575K
5
Millennium Management
Millennium Management
New York
-$501K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$25.3M +$3.2M +254,902 +15%
Vanguard Group
2
Vanguard Group
Pennsylvania
$15.8M -$347K -27,645 -2%
State Street
3
State Street
Massachusetts
$6.07M +$448K +35,695 +8%
SC
4
Skylands Capital
Wisconsin
$5.91M -$483K -38,500 -8%
Northern Trust
5
Northern Trust
Illinois
$4.66M +$646K +51,548 +17%
Allianz Asset Management
6
Allianz Asset Management
Germany
$4.52M +$1.16M +92,508 +36%
MHP
7
Manatuck Hill Partners
Connecticut
$3.91M +$565K +45,100 +17%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.67M +$572K +45,620 +19%
Invesco
9
Invesco
Georgia
$2.86M +$2.39M +190,969 +617%
USAA
10
United Services Automobile Association
Texas
$2.47M +$2.4M +191,603 New
GIM
11
Granahan Investment Management
Massachusetts
$2.42M +$2.35M +187,300 New
Two Sigma Advisers
12
Two Sigma Advisers
New York
$2.17M -$575K -45,851 -21%
RJA
13
Raymond James & Associates
Florida
$1.93M -$229K -18,300 -11%
EI
14
EAM Investors
California
$1.9M -$395K -31,506 -18%
BFS
15
Bradley Foster & Sargent
Connecticut
$1.86M +$61.8K +4,926 +4%
EGI
16
EAM Global Investors
California
$1.3M -$243K -19,366 -16%
JP Morgan Chase
17
JP Morgan Chase
New York
$1.27M -$1.25M -99,392 -50%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$1.22M +$146K +11,666 +14%
Morgan Stanley
19
Morgan Stanley
New York
$1.01M -$96.2K -7,672 -9%
Deutsche Bank
20
Deutsche Bank
Germany
$872K -$141K -11,209 -14%
Charles Schwab
21
Charles Schwab
California
$806K +$32.9K +2,627 +4%
WAP
22
Wealthcare Advisory Partners
Pennsylvania
$801K – – –
TA
23
Teachers Advisors
New York
$785K +$76.1K +6,069 +11%
GIP
24
Granite Investment Partners
California
$760K – – –
TCIM
25
TIAA CREF Investment Management
New York
$733K -$78.1K -6,232 -10%
1
2 3 4

CTSO Hedge Fund Activity: Q3 2018 in Review

79 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2018, worth a combined $106M — up 18% from $89.2M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CTSO positions and 9 closed out — a net gain of 5 holders — while 26 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $3.2M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.63M sold.

  • 79 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2018, up from 75 in Q2 2018.
  • Funds reported $106M of Cytosorbents Corp stock for Q3 2018, up 18% quarter-over-quarter.
  • 14 funds opened new Cytosorbents Corp positions in Q3 2018 and 9 closed out, a net change of +5 holders.
  • The largest Cytosorbents Corp buyer in Q3 2018 was BlackRock, an estimated $3.2M added.
  • The largest Cytosorbents Corp seller in Q3 2018 was Renaissance Technologies, an estimated $2.63M sold.

Based on aggregated 13F filings for Q3 2018.